Sharemaestro Newsreel

American Well Q2 Earnings Call Highlights

Earnings To Watch: Privia Health (PRVA) Reports Q2 Results Tomorrow

Privia Health Group (NASDAQ: PRVA) is set to report its Q2 earnings, with analysts expecting a 14.6% year-on-year revenue growth. The company has a history of exceeding Wall Street's expectations and beat revenue estimates last quarter, despite missing EPS estimates. Investors will be watching …

Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Director Anquillare Mark V

This article reports a change in the beneficial ownership of securities for Mark V. Anquillare, a Director at Teladoc Health. The filing is a Statement of Changes in Beneficial Ownership, also known as a Form 4. This indicates that there has been a transaction …

Certara (CERT) Stock Price Faces Loss Pressure Despite Software Gains

Certara's stock price declined 4.7% after its Q2 earnings report, despite a strong performance in its software segment. The company reported a net loss from continuing operations of US$6.1m, contrasting with a healthy 28.1% adjusted EBITDA margin. While software revenue increased and now constitutes …

Bronstein, Gewirtz & Grossman, LLC Encourages Certara, Inc. (CERT) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Certara, Inc. (NASDAQ:CERT) following a significant drop in its stock price. The investigation stems from Certara's Q1 2026 financial results, which reported declines in services revenue and bookings, and an …

Hinge Health (HNGE) CFO relinquishes shares to cover RSU tax withholding

Hinge Health's CFO, James Budge, reported an exempt transaction where he relinquished 4,614 shares of Class A Common Stock. These shares, valued at $74.71 each, were cancelled to cover federal and state tax withholding obligations stemming from the vesting of restricted stock units. Following …

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

SOPHiA GENETICS announced a global, multi-year collaboration with AstraZeneca to develop and commercialize two companion diagnostics (CDx) for precision oncology therapies. This partnership aims to integrate SOPHiA GENETICS's decentralized clinical trial assays and CDx capabilities to support AstraZeneca's treatments, focusing on both solid tumor …

American Well (NYSE:AMWL) Announces Quarterly Earnings Results

Amwell (NYSE: AMWL) tightens 2026 loss guidance after Q2 results

Amwell reported Q2 2026 revenue at $52.0 million, at the top of its guidance, and significantly improved its adjusted EBITDA loss to ($1.2) million. The company tightened its full-year 2026 revenue guidance to $200–$205 million and substantially narrowed its adjusted EBITDA loss outlook to …

Does Waystar Holding’s (WAY) CFO Transition Reshape the Story Around Its Upgraded 2026 Revenue Outlook?

Waystar Holding Corp. recently announced strong Q2 2026 results, raising its full-year revenue guidance to US$1.28–US$1.29 billion. This positive financial update coincides with a CFO transition, as Steve Oreskovich steps down and Alpana Wegner, with extensive experience in software and technology finance, takes over. …

VSee Health, Inc.(OTCPK: VSEE) dropped from NASDAQ Composite Index

VSee Health, Inc. (OTCPK:VSEE) has been removed from the NASDAQ Composite Index as of August 4, 2026. This news follows several recent developments for the company, including signing a letter of intent to acquire certain healthcare technology assets for $42 million and initiating a …

So-Young International Inc. Announces Appointment of Nan Shen to Chief Financial Officer, Effective August 3, 2026

So-Young International Inc. has appointed Ms. Nan Shen as its new Chief Financial Officer, effective August 3, 2026. In her new role, Ms. Shen will oversee the company's finance, human resources, legal, and compliance functions. She previously served as an independent director on the …

So-Young (Nasdaq: SY) taps director Nan Shen as chief financial officer

So-Young International Inc. (Nasdaq: SY) has appointed Nan Shen as its new Chief Financial Officer, effective August 3, 2026. Ms. Shen, who has been an independent director since October 2023, will oversee the company's finance, human resources, legal, and compliance functions. She brings extensive …

VSee Health Received Notice of Delisting

VSee Health received a delisting notice from Nasdaq on July 30, 2026, because its closing bid price fell below $0.10 for ten consecutive trading days. Trading of its securities will be suspended on August 6, 2026, and a Form 25-NSE will be filed. The …

So-Young appoints Nan Shen as new CFO to strengthen financial and operational leadership.

So-Young International Inc., a prominent aesthetic treatment platform in China, has announced the appointment of Ms. Nan Shen as its new Chief Financial Officer, effective August 3, 2026. Ms. Shen, formerly an independent board director and ex-CFO at Gaotu Techedu Inc., will now oversee …

Health Catalyst, Inc. expected to post earnings of 3 cents a share - Earnings Preview

Health Catalyst, Inc. (HCAT) is projected to report earnings of 3 cents per share. This earnings preview, sourced from Refinitiv via Reuters, indicates the anticipated financial performance for the company. The full article provides further details on these expectations.

Teladoc Health

This article provides an overview of Teladoc Health (TDOC), a company specializing in telehealthcare services. It details the company's profile, including its founding, headquarters, CEO, and employee count, alongside key financial statistics, stock price performance, and analyst consensus recommendations.

So-Young's New CFO Will Oversee Finance, HR and Legal

So-Young International (Nasdaq: SY) has appointed Nan Shen as its new Chief Financial Officer, effective August 3, 2026. Ms. Shen will be responsible for overseeing the company's finance, human resources, legal, and compliance functions. She previously served as CFO of Gaotu Techedu and will …

Director Mark V. Anquillare gets 37,425 RSUs at Teladoc Health (TDOC)

Teladoc Health director Mark V. Anquillare was granted 37,425 Restricted Stock Units (RSUs) on August 3, 2026. These RSUs, which represent a contingent right to one share of common stock each, will vest in a staggered manner: one-third on the first anniversary of the …

Jurgi Camblong (SOPH) plans 20,000-share sale and details 10b5-1 trades

Jurgi Camblong, an insider at SOPHiA GENETICS SA (SOPH), has filed a notice to sell 20,000 common shares totaling $113,800.00, with the sale expected on August 4, 2026. This filing also discloses previous Rule 10b5-1 sales, including 20,000 shares sold on July 21, 2026, …

SOPHiA GENETICS (SOPH) insider Zhenyu Xu plans 10,000-share stock sale

SOPHiA GENETICS insider Zhenyu Xu plans to sell 10,000 shares of common stock on NASDAQ, valued at approximately $56,900. These "Founders Shares" were acquired in 2012, and the sale is being conducted through Morgan Stanley Smith Barney LLC Executive Financial Services under a Rule …

HealthEquity Lists Three September Investor Conference Dates

HealthEquity (NASDAQ: HQY) announced its Q2 fiscal 2027 earnings release for August 27, 2026, followed by an investor conference call. Additionally, the company's management plans to present and meet with investors at three healthcare conferences in September 2026: the Wells Fargo Healthcare Conference, the …

Mangoceuticals Granted 180-Day Extension by Nasdaq to

Mangoceuticals Inc. (NASDAQ: MGRX) has received a 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement, pushing the deadline to February 1, 2027. The company is simultaneously advancing its business combination with Nuclea Energy Inc., which is developing the Morpheus …

Simulations Plus, Inc. (SLP) CRO sells 1,000 shares under Rule 10b5-1 plan

Simulations Plus, Inc.'s Chief Revenue Officer, John Anthony DiBella II, sold 1,000 shares of common stock on August 3, 2026, at $18.28 per share through a Rule 10b5-1 trading plan. Following this transaction, DiBella directly holds 85,140 shares. The sale was executed automatically and …

Definitive Healthcare (DH) CFO has 1,881 shares withheld to cover RSU taxes

Definitive Healthcare Corp. reported that its Chief Financial Officer, Casey Heller, had 1,881 shares of Class A Common Stock withheld on August 1, 2026. This action was taken to satisfy tax withholding obligations related to the vesting of previously reported Restricted Stock Units (RSUs). …

Definitive Healthcare Corp. (DH) chair has 12,166 shares withheld for tax

Definitive Healthcare Corp.'s Executive Chairman and 10% owner, Jason Ronald Krantz, had 12,166 Class A common shares withheld on August 1, 2026, to cover tax obligations from the vesting of Restricted Stock Units (RSUs) at a price of $0.6823 per share. Following this transaction, …

Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal

Mangoceuticals (NASDAQ: MGRX) has secured an additional 180-day extension from Nasdaq to meet the minimum bid price requirement, pushing the deadline to February 1, 2027. This extension provides the company flexibility as it progresses with a definitive business combination agreement with Nuclea Energy Inc., …

Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ...

Sophia Genetics (SOPH) reported record Q2 2026 revenue of $23.3 million, a 27% year-over-year increase, driven by strong U.S. and liquid biopsy revenue growth. The company raised its full-year 2026 revenue guidance to $94-$96 million and improved its adjusted EBITDA loss. Key strategic wins …

Waystar Holding (NASDAQ: WAY) CFO named as reporting insider with no trades

Waystar Holding Corp.'s Chief Financial Officer, Alpana Wegner, has been identified as a reporting person in a new Form 3 filing. This initial statement of beneficial ownership indicates no equity transactions, share holdings, or derivative positions for Wegner at this time. The filing establishes …

DarioHealth (DRIO) Projected to Release Quarterly Earnings on Tuesday

BTSG Raises 2026 Guidance as Specialty and Home Health Drive Growth

HealthStream Inc (HSTM) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Wins ...

HealthStream Inc. (HSTM) reported record Q2 2026 revenues of $83.7 million, up 12.5% year-over-year, and a record adjusted EBITDA of $20.6 million. The company achieved strong organic growth, particularly in CredentialStream, ShiftWizard, and myClinicalExchange, and increased its full-year guidance. Despite challenges from declining legacy …

HealthStream Sets $0.035 Dividend, Guides to $327M-$332M Revenue

HealthStream (HSTM) reported record Q2 2026 revenues of $83.7 million, a 12.5% increase year-over-year, with net income up 23.8% to $6.7 million and diluted EPS of $0.23. The company also declared a quarterly cash dividend of $0.035 per share and updated its full-year 2026 …

PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT:

Bernstein Liebhard LLP is investigating potential breaches of fiduciary duty by directors and officers of Phreesia, Inc. (NYSE: PHR). The firm encourages current Phreesia shareholders who purchased shares before May 8, 2025, to contact them to learn about their legal rights. The investigation aims …

Certara, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CERT) 2026-08-04

This article presents the slide deck published by Certara, Inc. in conjunction with their 2026 Q2 earnings call held on August 4, 2026. The company reported Q2 EPS of $0.08, missing by $0.01, and revenue of $93.27M, a 10.81% year-over-year decrease, missing by $4.81M. …

HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule

HealthEquity, Inc. (NASDAQ: HQY) has announced that it will release its financial results for the second quarter of fiscal year 2027 on Thursday, August 27, 2026, before market open. Management will host a conference call at 8:30 a.m. ET on the same day to …